Famotidine for injection

This product is a histamine H2 receptor blocker. It has a significant inhibitory effect on gastric acid secretion, and can also inhibit the secretion of pepsin, and has a certain protective effect on animal experimental ulcers. It takes effect about 1 hour after taking the medicine, and the effect can last for more than 12 hours.

The main ingredient of this product is famotidine. Its chemical name is 3-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N-sulfamoylpropionamidine. Molecular formula: C8H15N7O2S3, molecular weight: 337.45.

This product is a colorless or slightly yellow clear liquid.

It is suitable for peptic ulcer (gastric and duodenal ulcer), acute gastric mucosal lesions, reflux esophagitis and gastrinoma.

Oral administration: 20 mg (1 tablet) twice a day, after breakfast, dinner or before bedtime. A course of treatment is 4 to 6 weeks. The maintenance dose is halved after the ulcer heals.

A small number of patients may experience dry mouth, dizziness, insomnia, constipation, diarrhea, rash, facial flushing, leukopenia, and occasionally mild transient increase in transaminase.

It is contraindicated for patients who are allergic to this product or have severe renal insufficiency.

This product does not interact with liver cytochrome P450 enzymes, so it does not affect the metabolism of drugs such as theophylline, phenytoin, warfarin and diazepam, nor does it affect the body distribution of procainamide, etc. However, probenecid will inhibit the excretion of famotidine from the renal tubules.

Keep in a light-proof and airtight container.

20mg

Jincheng Haisi Pharmaceutical Co., Ltd.

• Founded in:

  1997-12-30

• Address:

  Wangtai, Jincheng City, Shanxi Province

• Tax NO.:

  91140500111208832X

• Registered Funds:

  148.512131 yuan

• Email:

  Log in to view